A Novel Benchmarking Approach to Assess the Agreement among Radiomic Tools.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 2 3 2022
medline: 26 5 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Background The translation of radiomic models into clinical practice is hindered by the limited reproducibility of features across software and studies. Standardization is needed to accelerate this process and to bring radiomics closer to clinical deployment. Purpose To assess the standardization level of seven radiomic software programs and investigate software agreement as a function of built-in image preprocessing (eg, interpolation and discretization), feature aggregation methods, and the morphological characteristics (ie, volume and shape) of the region of interest (ROI). Materials and Methods The study was organized into two phases: In phase I, the two Image Biomarker Standardization Initiative (IBSI) phantoms were used to evaluate the IBSI compliance of seven software programs. In phase II, the reproducibility of all IBSI-standardized radiomic features across tools was assessed with two custom Italian multicenter Shared Understanding of Radiomic Extractors (ImSURE) digital phantoms that allowed, in conjunction with a systematic feature extraction, observations on whether and how feature matches between program pairs varied depending on the preprocessing steps, aggregation methods, and ROI characteristics. Results In phase I, the software programs showed different levels of completeness (ie, the number of computable IBSI benchmark values). However, the IBSI-compliance assessment revealed that they were all standardized in terms of feature implementation. When considering additional preprocessing steps, for each individual program, match percentages fell by up to 30%. In phase II, the ImSURE phantoms showed that software agreement was dependent on discretization and aggregation as well as on ROI shape and volume factors. Conclusion The agreement of radiomic software varied in relation to factors that had already been standardized (eg, interpolation and discretization methods) and factors that need standardization. Both dependences must be resolved to ensure the reproducibility of radiomic features and to pave the way toward the clinical adoption of radiomic models. Published under a CC BY 4.0 license.

Identifiants

pubmed: 35230182
doi: 10.1148/radiol.211604
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

533-541

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Auteurs

Andrea Bettinelli (A)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Francesca Marturano (F)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Michele Avanzo (M)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Emiliano Loi (E)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Enrico Menghi (E)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Emilio Mezzenga (E)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Giovanni Pirrone (G)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Anna Sarnelli (A)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Lidia Strigari (L)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Silvia Strolin (S)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Marta Paiusco (M)

From the Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128 Padua, Italy (A.B., F.M., M.P.); Department of Information Engineering, University of Padova, Padua, Italy (A.B.); Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy (M.A., G.P.); Medical Physics Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy (E.L., E. Menghi, E. Mezzenga, A.S.); and IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy (L.S., S.S.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH